The Menopausal Vulva and Vagina: Vestibulodynia or GSM and Treatment
Image For Activity Cover
Availability
Registration Required
Access expires on Aug 18, 2025
Online Meeting
Jun 18, 2025 7:00 PM - 8:00 PM ET
Cost
Member: $0.00
Non-Member: $50.00
Fellow: $0.00
Student: $0.00
Affiliate: $0.00
Fellow-Program: $0.00
Credit Offered
1 CME Credit

Understanding the postmenopausal vulva and vagina can be difficult. These separate tissues are often confused by patients and undertreated by the entire medical profession. This lecture will define the anatomy and focus on two specific clinical entities: 1) vulvar vestibulodynia, and 2) genitourinary syndrome of menopause (GSM), formerly vulvovaginal atrophy (VVA). After a brief introduction to these separate disorders, approaches to evidence-based management will be thoroughly reviewed.

Upon completion of this lecture, participants will be able to:

  • Recognize the clinical manifestations of hormone mediated vestitibulodynia (VVS), and Genitourinary Syndrome of Menopause (GSM; formerly VVA) and their underlying pathophysiology.
  • Appreciate the profound impact VVS, GSM, and their associated symptoms have on sexual function.
  • Apply evidence-based treatment options, hormonal, nonhormonal, and energy-based (devices) to the management of VVS and GSM.

Dr. James A. Simon is Clinical Professor of Ob/Gyn at George Washington University in Washington DC. A board-certified obstetrician-gynecologist, reproductive endocrinologist, and AASECT-Certified Sexuality Counsellor, Dr. Simon’s private medical practice, IntimMedicine Specialists® (www.IntimMedicine.com), focuses on complicated gynecology, reproductive endocrinology, menopause, and sexual health. His pioneering experience utilizing both hormonal and non-hormonal therapies for menopausal and sexual problems has resulted in numerous awards including: “Top Washington Physicians,” “America’s Top Obstetricians and Gynecologists,” “Super Doctors of Washington DC-Baltimore-Northern Virginia,” and “The Best Doctors in America.” Dr. Simon is the only physician to serve as President of both The Menopause Society and the International Society for the Study of Women’s Sexual Health. Nicknamed “The Menopause Whisperer” by Washingtonian Magazine, Dr. Simon received both the NAMS-Leon Speroff Outstanding Educator Award and the ISSWSH-Distinguished Service Award. Dr. Simon is an established clinical investigator--completing more than 400 clinical research trials, and he’s also a prolific author—with more than 800 published articles, abstracts, chapters, proceedings, and the paperback book: Restore Yourself: A Woman’s Guide to Reviving Her Sexual Desire and Passion for Life.

Padma Kandadai, MD | Boston University School of Medicine 



The American Urogynecologic Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Urogynecologic Society designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the American Urogynecologic Society (AUGS) requires that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies. AUGS mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AUGS seeks to verify that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AUGS is committed to providing learners with high-quality CME.

Faculty Disclosures

James Simon has disclosed the following relationships:
  • Abbvie - Researcher; Private Investiagtor
  • Ascenf Therapeutics - Consultant/advisory board; Speakers Bureau
  • Bayer Healther - Grant/research support; Consulting/advisory board
  • Besin Healthcare/Vella Bioscience - Consulting/advisory board
  • Lawley Pharmaceticals Pty Ltd - Speaker fees
  • Mayne Pharma - Consulting; Speaker Bureau
  • Mylan/Viatris - Grant/research support
  • Myovent Sciences - Grant/research support; Speaker Bureau
  • Pharmavite - Speaker Bureau
All relevant financial conflicts have been mitigated.

Planner and Staff Disclosures

None of the other planners, reviewers, or AUGS staff have any relevant financial relationships to disclose.
Powered By